Larry C. Buckelew Net Worth

The estimated Net Worth of Larry C. Buckelew is at least $5.34 Milione dollars as of 28 March 2016. Larry Buckelew owns over 100,000 units of Global X Funds stock worth over $5,344,641 and over the last 15 years Larry sold AIQ stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Larry Buckelew AIQ stock SEC Form 4 insiders trading

Larry has made over 2 trades of the Global X Funds stock since 2011, according to the Form 4 filled with the SEC. Most recently Larry exercised 100,000 units of AIQ stock worth $485,000 on 28 March 2016.

The largest trade Larry's ever made was exercising 100,000 units of Global X Funds stock on 28 March 2016 worth over $485,000. On average, Larry trades about 9,231 units every 130 days since 2009. As of 28 March 2016 Larry still owns at least 154,202 units of Global X Funds stock.

You can see the complete history of Larry Buckelew stock trades at the bottom of the page.

What's Larry Buckelew's mailing address?

Larry's mailing address filed with the SEC is 100 BAYVIEW CIRCLE, SUITE 400, NEWPORT BEACH, CA, 92660.

Insiders trading at Global X Funds

Over the last 21 years, insiders at Global X Funds have traded over $406,216,779 worth of Global X Funds stock and bought 11,973,300 units worth $47,156,496 . The most active insiders traders include Henry R Kravis, James H Jr Greene e Alexandar Jrraether Paul Er.... On average, Global X Funds executives and independent directors trade stock every 92 days with the average trade being worth of $57,648,557. The most recent stock trade was executed by Rhonda A Longmore Grund on 19 May 2016, trading 2,500 units of AIQ stock currently worth $18,975.

What does Global X Funds do?

Complete history of Larry Buckelew stock trades at Global X Funds

Global X Funds executives and stock owners

Global X Funds executives and other stock owners filed with the SEC include:

• R Brian Hanson,
  Executive VP & CFO
• Russell D Jr Phillips,
  EVP, Gen.Coun.,Secre.
• Henry R Kravis,
  Director
• Kenneth S Ord,
  Executive VP & CFO
• Rhonda A Longmore Grund,
  EVP and CFO
• Heping Feng,
  
• Tao L. Zhang,
  
• Edward L Samek,
  Director
• Richard A. Jones,
  Executive Vice President
• Neil F Dimick,
  Director
• Paul S Viviano,
  Chairman, President & CEO
• Richard W Johns,
  EVP, General Counsel & Sec.
• Percy C Jr Tomlinson,
  President & CEO
• Gregory E. Spurlock,
  President. Alliance Oncology
• Christianna S Rosow,
  Principal Accounting Officer
• Scott A Bartos,
  Director
• Larry C. Buckelew,
  Director
• Howard K Aihara,
  VP & Corporate Controller
• Deborah Rodriguez,
  EVP, Human Resources
• Michael J Shea,
  Chief Operating Officer
• Nicholas A Poan,
  VP, Corporate Controller
• Eli H Glovinsky,
  Exec.VP,Gen.Coun,Corp.Secre.
• Michael F Frisch,
  Executive Vice President & COO
• Richard J Hall,
  President, Alliance Oncology
• Curtis Lane,
  Director
• Christopher J Joyce,
  Executive Vice President, M&A
• Aaron Bendikson,
  Director
• Health Investors Ii, Lp All...,
  
• Anthony B Helfet,
  Director
• Principal Opportunities Fun...,
  
• Michael P Harmon,
  Director
• Health Investors Ii, Lp All...,
  
• Alexandar Jrraether Paul Er...,
  
• James C Momtazee,
  Director
• Michael W Michelson,
  Director
• Kenneth W/Nj Freeman,
  Director
• 1996 Gp Llckkr Associates 1...,
  
• James H Jr Greene,
  Director
• Adam Clammer,
  Director
• Andrew P Hayek,
  Executive VP & COO